CRWD vs JNJ: Which Is the Better Buy?

Side-by-side comparison of CrowdStrike Holdings, Inc. and Johnson & Johnson β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-24.
CrowdStrike Holdings, Inc. Β· Technology
$436.32
+34.6% upside to fair value
Grade B
VS
Johnson & Johnson Β· Healthcare
$230.69
+10.8% upside to fair value
Grade C High Quality
QuantHub Verdict
CRWD has more upside to fair value (+34.6%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric CRWD JNJ
Current Price $436.32 $230.69
Fair Value Estimate $587.16 $255.61
Upside to Fair Value +34.6% +10.8%
Market Cap $110.7B $555.9B
Forward P/E -601.6x 26.8x
EV / EBITDA 951.5x 18.5x
Price / Sales 23.0x 5.8x
Price / FCF 89.3x 28.2x
Revenue Growth YoY +23.3% +9.9%
Gross Margin 74.9% 69.1%
Operating Margin -5.4% 26.9%
Return on Equity -4.7% 26.5%
Dividend Yield 0% 0%
FCF Yield 1.12% 3.54%
Analyst Consensus Buy Buy
Investment Thesis
CRWD β€” CrowdStrike Holdings, Inc.
CrowdStrike Holdings, Inc. is a leading cybersecurity company specializing in cloud-based endpoint protection and threat intelligence, with a dominant subscription revenue model accounting for over 95% of total revenue. The business quality is medium due to strong revenue growth of 23.3% in the most recent quarter and a robust earnings growth of 141.9% in the same period, supported by a high gros…
JNJ β€” Johnson & Johnson
Johnson & Johnson is a leading healthcare company focused on pharmaceuticals and medical devices following its consumer health spin-off. The business quality is high due to its durable competitive moat, diversified portfolio, and strong management with deep institutional knowledge. Despite a 52.4% decline in earnings in the most recent quarter, revenue grew 9.9% year-over-year in the same period,…
Accumulation Zones
Metric CRWD JNJ
Zone Low $440.37 $191.71
Zone High $499.09 $217.27
In Buy Zone? Yes No
← CRWD Research    JNJ Research β†’    All Research